{"doi":"10.24996/ijs.2023.64.9.8","title":"C-reactive Protein of Clinical Outcomes in COVID-19 Basra Patients","abstract":"<jats:p>     By the time we conducted the current study,- COVID-19 epidemic has already become a global challenge, paralyzing socio-economic activity dramatically.\n Hence   , this study aimed to identify the most valuable prognostic indicators for COVID19 patients' early and accurate diagnosis by comparing laboratory biomarkers like C -reactive protein between non-severe and severe groups of patients. Depending on clinical symptoms, ---337 COVID-19 patients were enrolled at the Basra City Hospital from March 29 to April 29,2020   were classified into severe and non severe groups.\n        A total of 337 patients were diagnosed with COVID-19, including 306 (128 males and 178 females) were adult patients, and  ---31 (10 male and 21 female) Child &amp; teens patients. The mean age of the adult patients was 42.79±16.22 (age rnage 18-85 years),----- Child &amp; teens patients was 12.23± 4.06. All children and more adults had an initial normal C-reactive protein (CRP) &lt;5 mg/L.\n       CRP in severe group (68.51±66.38) was assigned to 27 adult patients (8.82%), and the differences were high significantly (p &lt;0.05) compared to the noﱟn severe group (24.31±45.26). There were significant differences (p&lt;0.05) between the severe group and non- severe groups in all parameters, including hemoglobin, platelet count, white blood cells (WBCs) count, CRP, ferritin as well as erythrocyte sedimentation rate ″ESR″.        \n ---The results of this study indicated,--- that in the majority of children ----with COVID-19 infection , threre was no  increase in  CRP levels and other biomarkers.On the other hand,  a positive link was found  between COVID-19 severity and CRP, ESR, and ferritin levels in adults.</jats:p>","journal":"Iraqi Journal of Science","year":2023,"id":12487,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.0422,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-09-30","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":98203,"name":"Saad Waheed","orcid":null,"position":1,"is_corresponding":false},{"id":98204,"name":"Abeer Al Sawafi","orcid":null,"position":2,"is_corresponding":false},{"id":98202,"name":"Alaa A. Saleh","orcid":"0000-0002-8876-5264","position":0,"is_corresponding":true}],"reference_count":41,"raw_metadata":null,"created_at":"2026-03-01T18:20:47.508186Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}